Open Access
| Issue |
BIO Web Conf.
Volume 172, 2025
International Conference on Nurturing Innovative Technological Trends in Engineering – BIOscience (NITTE-BIO 2025)
|
|
|---|---|---|
| Article Number | 02012 | |
| Number of page(s) | 10 | |
| Section | Bioinformatics / Computational Biology | |
| DOI | https://doi.org/10.1051/bioconf/202517202012 | |
| Published online | 10 April 2025 | |
- B.B. Aggarwal, K.B. Harikumar, S.C. Gupta. Curcumin: A review of its’ anti- inflammatory and antioxidant properties, and role in diseases and symbiotic relationships. Bio Factors, 35, 78-85 (2009). doi:10.1002/biof.32 [Google Scholar]
- A.C. Bharti, Y. Takada, B.B. Aggarwal. Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation and induces apoptosis in human Mantle Cell Lymphoma. Bio chem. Pharmacol., 68, 933-942 (2004). doi:10.1016/j.bcp.2004.05.027 [CrossRef] [Google Scholar]
- C. Jobin, C.A. Bradham, M.P. Russo, B. Juma, A.S. Narula, D.A. Brenner, R.B. Sartor. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor IκB kinase activity. J. Immunol., 163, 3474-3483 (1999). [CrossRef] [PubMed] [Google Scholar]
- M. Shakibaei, T. John, G. Schulze-Tanzil, I. Lehmann, S. Möller. Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase 9 in human articulate chondrocytes: Biochemical basis for anti-inflammatory and anti-catabolic effects of curcumin in arthritis. Biochemical Pharmacology, 73(11), 1434-1445. doi: 10.1016/j.bcp.2007.01.017 [CrossRef] [PubMed] [Google Scholar]
- K. Kaur, A.K. Al-Khazaleh, D.J. Bhuyan, F. Li, C.G. Li. A review of recent curcumin analogues and their antioxidant, anti-inflammatory, and anticancer activities. Antioxidants, 13(9) (2024) [Google Scholar]
- N. Ghosh, R. Chaki, V. Mandal, S.C. Mandal. COX-2 as a target for cancer chemotherapy. Pharmacol. Rep., 62, 233-244 (2010). [CrossRef] [Google Scholar]
- X. Dolcet, D. Llobet, J. Pallares, X. Matias-Guiu. NF-κB in development and progression of human cancer. Virchows Arch., 446, 475-482 (2005). [CrossRef] [PubMed] [Google Scholar]
- C.A. Mosley, D.C. Liotta, J.P. Snyder. Highly active anticancer curcumin analogues. Mol. Targets Ther. Uses Curcumin Health Dis., 77, 103 (2007). [Google Scholar]
- A. Kumar, S. Kumar Singh, V. Kumar. Curcumin: A natural NF-κB inhibitor in cancer. J. Pharm. Pharmacol., 70, 1141-1155 (2018). doi:10.1111/jphp.12963 [Google Scholar]
- A. Greenhough, H.J. Smartt, A.E. Moore, H.R. Roberts, A.C. Williams, C. Paraskeva, A. Kaidi. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptations to the tumour microenvironment. Carcinogenesis, 30, 377-386 (2009). [CrossRef] [PubMed] [Google Scholar]
- A. Zarghi, S. Arfaei. Selective COX-2 inhibitors: A review of their structure-activity relationships. Iran. J. Pharm. Res., 10, 655-683 (2011). [Google Scholar]
- S. Vadhan-Raj, D.M. Weber, M. Wang, S.A. Giralt, S.K. Thomas, R. Alexanian, B.B. Aggarwal. Curcumin downregulates NF-κB and related genes in patients with multiple myeloma: results of a Phase I/II study. Blood, 110, 1177-1177 (2007). [CrossRef] [Google Scholar]
- G. Bitencourt-Ferreira, W.F. de Azevedo. Docking screens for drug deliveries: Docking with Swiss Dock. Methods Mol. Biol., 2053, 189-202 (2019). [CrossRef] [PubMed] [Google Scholar]
- J. Sang, J. Chu, X. Zhao, H. Quan, Z. Ji, S. Wang, Y. Tang. Curcuminoids inhibit human and rat p lacental 3β-hydroxysteroid dehydrogenases: Structure-activity relationship and in silico docking analysis. J. Ethnopharmacol., 305, 113892 (2022). [Google Scholar]
- D. Sahu, L.S. Rathor, S.D. Dwivedi, K. Shah, N.S. Chauhan, M.R. Singh, D. Singh. A review on molecular docking as an interpretative tool for molecular targets in disease management. Assay Drug Dev. Technol., 22, 40-50 (2024). [CrossRef] [PubMed] [Google Scholar]
- J.S. Jurenka. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev., 14, 141-153 (2009). [Google Scholar]
- P.D. Kasi, R. Tamilselvam, K. Skalicka-Woźniak, S.F. Nabavi, M. Daglia, A. Bishayee, S.M. Nabavi. Molecular targets of curcumin for cancer therapy: an updated review. Tumor Biol., 37, 13017-13028 (2016). [CrossRef] [PubMed] [Google Scholar]
- Y. Sumanont, Y. Murakami, M. Tohda, O. Vajragupta, H. Watanabe, K. Matsumoto. Effects of manganese complexes of curcumin and diacetyl curcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. Biol. Pharm. Bull., 30, 1732-1739 (2007). [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.